Our growth strategy includes ambitious expansion plans across new territories and therapeutic areas via acquisition.
Recent acquisition success includes POA Pharma, a northern European Pharmaceutical company, which we took full control over in January 2020. POA Pharma has doubled its employee numbers, added new locations, and launched new products under our leadership.
We continue to look for opportunities that align with our growth strategy.